MMP19 and metabolic dysfunction-associated steatotic liver disease: Whilst this study did not verify general benefits of RASi use on NAFLD development or progression, it did substantiate the role of RASi in specific clinical situations and offers valuable insight into the clinical implications of RASi on NAFLD.